Latest News about FDA
Recent news which mentions FDA
FDA Developing Regulating Pathways For Cannabis-Derived Ingredients In Foods, Supplements; Oversight Plans Expected In Few Months
December 28, 2022
From Benzinga
FDA Considers Regulating CBD In Foods & Supplements, Plans To Study Pregnancy And Daily Use
December 27, 2022
From Benzinga
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
From Benzinga
Roche's Follicular Lymphoma Therapy Scores FDA Approval
December 23, 2022
From Benzinga
DBV Technologies Shares Jumps As FDA Lifts Partial Hold On Pivotal Trial For Peanut Allergy Patch
December 23, 2022
Tickers
DBVT
From Benzinga
FDA Approves Gilead's New HIV Treatment For Heavily Treated With Multi-Drug Resistant Patients
December 22, 2022
Tickers
GILD
From Benzinga
FDA Approves Roche's Tocilizumab As First Monoclonal Antibody For COVID-19 Treatment
December 22, 2022
From Benzinga
After Tests, Recalled DreamStation Sleep Devices Unlikely To Cause Harm, Philips Says
December 21, 2022
Tickers
PHG
From Benzinga
Magenta Therapeutics Shares Crashes As Dose-Limiting Toxicities Observed In Lead Blood Cancer Study
December 20, 2022
Tickers
MGTA
From Benzinga
FDA Allows Bluebird Bio To Resume Sickle Cell Disease Studies In Patients Below 18, With Changed Protocol
December 19, 2022
Tickers
BLUE
From Benzinga
Psychedelics Will Be Legal In Most U.S. States Within 15 Years, According To JAMA Analysis
December 19, 2022
From Benzinga
Israeli Psychedelics Biotech Shares Latest Advancements, Moves Forward With Addictions Treatment
December 19, 2022
Tickers
CMND
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.